News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Esperion Therapeutics, Inc. Co-Founder Dr. Jan Johansson Joins Resverlogix Corporation As Senior Vice President Of Clinical Affairs
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Resverlogix Corp. (TSX-V:RVX) today announced the appointment of Jan O. Johansson, M.D., Ph.D., as Senior Vice President of Clinical Affairs.
Twitter
LinkedIn
Facebook
Email
Print
People
Esperion Therapeutics Inc.
MORE ON THIS TOPIC
Manufacturing
Sun Pharma recalls cancer drug after finding glass particles in some vials
May 15, 2026
·
2 min read
·
Nick Paul Taylor
Drug Development
Biogen’s Alzheimer’s results bolster tau theory—and Denali’s next gen candidate
May 15, 2026
·
3 min read
·
Annalee Armstrong
Series B
CREATE jumps into CAR T competition with $122M series B
May 15, 2026
·
2 min read
·
Tristan Manalac
FDA
Biotech leaders pitch Pazdur as next FDA chief
May 14, 2026
·
2 min read
·
Annalee Armstrong
